EcoDrugPlus

Receptor Activity Modifying Protein 1

Ensembl ID : ENSCAFG00020024626
Gene Symbol: RAMP1
3 Cross references
252 Possible Orthologues:

Receptor Interacting Serine/threonine Kinase 1

Ensembl ID : ENSCAFG00020000428
Gene Symbol: RIPK1
1 Cross references
198 Possible Orthologues:

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSCAFG00020008688
Gene Symbol: RPTOR
3 Cross references
208 Possible Orthologues:

Renin

Ensembl ID : ENSCAFG00020006703
Gene Symbol: REN
3 Cross references
220 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSCAFG00020025280
Gene Symbol: RET
3 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Alpha

Ensembl ID : ENSCAFG00020018727
Gene Symbol: RARA
3 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSCAFG00020024755
Gene Symbol: RARB
3 Cross references
451 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSCAFG00020021255
Gene Symbol: RARG
3 Cross references
451 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSCAFG00020024843
Gene Symbol: RXRA
3 Cross references
249 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSCAFG00020003098
Gene Symbol: RXRB
3 Cross references
215 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSCAFG00020001975
Gene Symbol: RXRG
3 Cross references
277 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSCAFG00020020012
Gene Symbol: RPL11
3 Cross references
196 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).